Eric Janezic, Ph.D.Principal Scientist at GenentechSpeaker
Profile
Eric obtained his PhD in Pharmacology from the University of Washington studying the regulation of GPCR trafficking. In 2021, he joined the Biochemical and Cellular Pharmacology department at Genentech, where he leads a lab responsible for determining biophysical parameters controlling the interactions of therapeutic candidates on living cells for projects across early- and late-stage research portfolios. In this capacity, Eric is passionate about evaluating and implementing cutting edge technologies that will address complex challenges in his field of expertise.
Agenda Sessions
A Novel, Label-free Assay to Determine the Binding Kinetics of Therapeutic Antibodies on Living Cells
, 11:00amView Session